Milademetan in Advanced/Metastatic Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Head and Neck Carcinoma|Cholangiocarcinoma|Sarcoma|Lung Adenocarcinoma|Bladder Urothelial Carcinoma|Stomach Adenocarcinoma|Breast Cancer Invasive|Ovarian Carcinoma|Cervical Cancer|Non Small Cell Lung Cancer|Gastric Cancer|Biliary Tract Cancer|Melanoma|Pancreas Cancer|MDM2 Gene Amplification|Testicular Germ Cell Tumor|Adrenocortical Carcinoma
Interventions: DRUG: RAIN-32
Sponsor: Rain Oncology Inc